Literature DB >> 30767696

Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.

Nienke Halbmeijer1, Michael Groeneweg1, Lissy De Ridder2.   

Abstract

INTRODUCTION: The onset of inflammatory bowel disease (IBD) in children is rising. Current treatment options are based on immunomodulatory therapy. Alternative treatment options are upcoming since they appear to be effective in individual patients. Cannabis might relief IBD symptoms in these cases and improve quality of life. Recent evidence suggests a potential anti-inflammatory effect of cannabis. Areas covered: This review presents an overview of recent literature on the use of cannabis in IBD focussing on pediatric IBD patients. Background information on the role of the endocannabinoid system within the gastrointestinal tract is presented. Other modalities of cannabis and its purified ingredients will be discussed as well, with attention to its applicability in children with IBD. Expert opinion: More research is needed on the efficacy and safety of cannabis in pediatric IBD. Studies are well underway, but until then the use of cannabis in pediatric IBD cannot be recommended.

Entities:  

Keywords:  Adolescents; cannabidiol; cannabis; children; endocannabinoid system; inflammatory bowel disease; medical marijuana; pediatric

Mesh:

Substances:

Year:  2019        PMID: 30767696     DOI: 10.1080/17512433.2019.1582330

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  1 in total

Review 1.  Current overview of opioids in progression of inflammatory bowel disease; pharmacological and clinical considerations.

Authors:  Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Nadia Zandi; Benyamin Pazoki; Atiyeh Rezaei; Mehrnoosh Hashemi; Saeideh Momtaz; Roja Rahimi; Maryam Shayan; Ahmad Reza Dehpour; Amir Hossein Abdolghaffari
Journal:  Mol Biol Rep       Date:  2021-01-04       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.